Skip to content

Author

Pradeep Natarajan

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clonal haematopoiesis subtypes confer dose-dependent risk of serious bacterial infection

Clonal haematopoiesis (CH) arises from somatic mutations in haematopoietic stem cells that drive clonal expansion and increase haematological malignancy risk. Here we show that CH confers mutation- and dose-dependent risk of serious bacterial infection (SBI). Using a multi-parameter somatic variant calling and filterin...

Eleanor Fewings, Z. Yu, Jacob C. Gutierrez et al. · 0 citations
Review Oct 2026

Small Interfering RNA in Cardiovascular Disease: A New Frontier in Precision Medicine.

Despite advances in traditional lipid-lowering, antithrombotic, and antihypertensive therapies, cardiovascular disease remains the leading cause of mortality worldwide. Small interfering RNA (siRNA) therapeutics harness the endogenous RNA interference pathway to degrade target messenger RNA, thereby reducing synthesis...

K. Paruchuri, Jaiden I. Busso, Pradeep Natarajan · 0 citations
Open access Sep 2026

Comparison of Performance of Publicly Available Polygenic Risk Scores to Predict Clinically Actionable Coronary Artery Calcium Scores: The BioHEART-CT Cohort.

AIM Coronary artery disease (CAD) remains the leading cause of morbidity and mortality globally. Polygenic Risk Scores (PRS) have been trained against major adverse cardiovascular outcomes (MACE) in large cohorts. Few studies have examined the effectiveness of these CAD MACE PRS tools in detecting individuals with subc...

M. Gray, D. Strbenac, Daniel Brieger et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.